$5.1亿
申报组合市值
| # | 证券 | 股数 | 股数环比 | 市值 | 占其组合 |
|---|---|---|---|---|---|
| 1 | KNSA Kiniksa Pharmaceuticals Intl | 918,070 | +20.6% | $5871万 | 11.5% |
| 2 | RLAY Relay Therapeutics Inc | 3.0M | +0.0% | $5583万 | 11.0% |
| 3 | LBRX Lb Pharmaceuticals Inc | 1.4M | +0.0% | $4466万 | 8.8% |
| 4 | RLMD Relmada Therapeutics Inc | 6.4M | +2.1% | $4423万 | 8.7% |
| 5 | ANRO Alto Neuroscience Inc | 1.4M | +2.1% | $3571万 | 7.0% |
| 6 | DNTH Dianthus Therapeutics Inc | 354,816 | −4.9% | $3459万 | 6.8% |
| 7 | ALKS Alkermes Plc | 543,876 | +71.0% | $2850万 | 5.6% |
| 8 | SVRA Savara Inc | 3.5M | +2.1% | $2127万 | 4.2% |
| 9 | PCVX Vaxcyte Inc | 306,047 | +24.6% | $1779万 | 3.5% |
| 10 | ELVN Enliven Therapeutics Inc | 329,006 | +0.0% | $1670万 | 3.3% |
| 11 | ENTA Enanta Pharmaceuticals Inc | 1.1M | +16.7% | $1587万 | 3.1% |
| 12 | CATX Perspective Therapeutics Inc | 3.7M | +40.6% | $1260万 | 2.5% |
| 13 | IFRX Inflarx Nv | 5.4M | — | $1199万 | 2.4% |
| 14 | SRZN Surrozen Inc | 432,040 | +0.0% | $1121万 | 2.2% |
| 15 | ALMS Alumis Inc | 392,574 | +0.0% | $1105万 | 2.2% |
| 16 | IPSC Century Therapeutics Inc | 4.1M | +0.0% | $994万 | 2.0% |
| 17 | NERV Minerva Neurosciences Inc | 1.7M | +0.0% | $919万 | 1.8% |
| 18 | SABS Sab Biotherapeutics Inc | 2.2M | +0.0% | $857万 | 1.7% |
| 19 | ANTX An2 Therapeutics Inc | 1.7M | +0.0% | $804万 | 1.6% |
| 20 | ERAS Erasca Inc | 422,543 | +0.0% | $774万 | 1.5% |
| 21 | IKT Inhibikase Therapeutics Inc | 3.6M | +0.0% | $727万 | 1.4% |
| 22 | RACC Research Alliance Corp Iii | 500,000 | — | $535万 | 1.0% |
| 23 | HLXC Helix Acquisition Corp Iii | 500,000 | +0.0% | $532万 | 1.0% |
| 24 | ZLAB Zai Lab Ltd | 279,110 | — | $530万 | 1.0% |
| 25 | QUIT Achieve Life Science Inc | 736,637 | — | $481万 | 0.9% |
| 26 | LXEO Lexeo Therapeutics Inc | 928,593 | +0.0% | $432万 | 0.8% |
| 27 | ALEC Alector Inc | 2.1M | +0.0% | $422万 | 0.8% |
| 28 | LONA Leonabio Inc | 393,701 | +0.0% | $362万 | 0.7% |
| 29 | CRVS Corvus Pharmaceuticals Inc | 231,585 | +0.0% | $346万 | 0.7% |
| 30 | JATT Jatt Ii Acquisition Corp | 160,000 | — | $182万 | 0.4% |